Foghorn Therapeutics Inc (FHTX)
$2.08 -0.48% Close Oct 30, 2026 Live
Foghorn Therapeutics stock today
Foghorn Therapeutics closed at $2.08 on October 30, 2026, down 0.48% on the day. Over the past year it returned -51.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $122 million.
$2.00$4.00$6.00
NovJan 2026MarMayJulSep
| Period | FHTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -41.7% | -0.9% |
| 3 months | -56.1% | +2.1% |
| Year to date | -61.5% | +11.7% |
| 1 year | -51.7% | +12.4% |
| 3 years | -40.4% | +88.5% |
| 5 years | -83.6% | +76.0% |
Key statistics
- Market value
- $122M
- Price / sales
- 3.3
- 52-week range
- $1.85 to $7.07
- Next report
- Nov 5, 2026 (estimated)
About Foghorn Therapeutics
Develops small molecule therapeutic drugs for cancer and related diseases.
Sector: Health Care
More on Foghorn Therapeutics
- Financials: revenue, earnings and segmentsRevenue +37% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $163.91 today
No forecast, no recommendation. This page describes Foghorn Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.